Kazia Therapeutics (KZIA) Institutional Ownership $0.82 -0.07 (-7.40%) As of 03:41 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Kazia Therapeutics (NASDAQ:KZIA)CurrentInstitutional OwnershipPercentage30.89%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$6.08MNumber ofInstitutional Sellers(last 12 months)0 Get KZIA Insider Trade Alerts Want to know when executives and insiders are buying or selling Kazia Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data KZIA Institutional Buying and Selling by Quarter Remove Ads Kazia Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2025 Barclays PLC120,000$212K0.0%N/A2.381% 11/7/2024 MAI Capital Management1,363,894$586K0.0%N/A51.663% 2/14/2024 Platinum Investment Management Ltd.1,821,887$801K0.0%N/A11.150% 2/13/2024 Armistice Capital LLC2,475,555$1.09M0.0%N/A15.150% 3/6/2023 OLD Mission Capital LLC42,765$26K0.0%-47.2%0.308% 11/14/2022 OLD Mission Capital LLC80,923$89K0.0%N/A0.583% 7/29/2022 SG Americas Securities LLC13,988$59K0.0%-41.5%0.106% 4/29/2022 SG Americas Securities LLC23,899$184K0.0%-29.9%0.181% 2/7/2022 SG Americas Securities LLC34,106$288K0.0%-14.3%0.258% 2/4/2022 Envestnet Asset Management Inc.26,412$223K0.0%N/A0.200% 11/1/2021 SG Americas Securities LLC39,776$450K0.0%-10.4%0.301% 10/21/2021 Total Clarity Wealth Management Inc.4,755$54K0.0%N/A0.036% 8/13/2021 Renaissance Technologies LLC65,823$649K0.0%+188.2%0.508% 8/12/2021 SG Americas Securities LLC44,398$438K0.0%+12.1%0.343% 5/18/2021 Morgan Stanley230,801$2.86M0.0%+28.5%1.781% 5/13/2021 SG Americas Securities LLC39,616$491K0.0%N/A0.419% 5/13/2021 Renaissance Technologies LLC22,840$283K0.0%-71.3%0.241% 2/18/2021 Truist Financial Corp35,260$304K0.0%-45.4%0.373% 2/10/2021 Renaissance Technologies LLC79,625$688K0.0%+2.7%0.842% (Data available from 1/1/2016 forward)Remove Ads KZIA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of KZIA shares? During the previous two years, the following institutional investors and hedge funds held shares of Kazia Therapeutics shares: Armistice Capital LLC ($1.09M), Platinum Investment Management Ltd. ($801K), and MAI Capital Management ($586K), Barclays PLC ($212K).Learn more on KZIA's institutional investors. What percentage of Kazia Therapeutics stock is owned by institutional investors? 30.89% of Kazia Therapeutics stock is owned by institutional investors. Learn more on KZIA's institutional investor holdings. Which institutional investors have been buying Kazia Therapeutics stock? The following institutional investors have purchased Kazia Therapeutics stock in the last 24 months: Armistice Capital LLC ($2.48M), Platinum Investment Management Ltd. ($1.82M), MAI Capital Management ($1.36M), and Barclays PLC ($120K). How much institutional buying is happening at Kazia Therapeutics? Institutional investors have bought a total of 5,781,336 shares in the last 24 months. This purchase volume represents approximately $24.96M in transactions. Related Companies EGRX Major Shareholders INAB Major Shareholders MTEX Major Shareholders CLRB Major Shareholders SNTI Major Shareholders EDSA Major Shareholders BCAB Major Shareholders CMMB Major Shareholders BFRG Major Shareholders ELEV Major Shareholders This page (NASDAQ:KZIA) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kazia Therapeutics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Kazia Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.